Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Degols

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Intracellular distribution of microinjected antisense oligonucleotidesJ P Leonetti, N Mechti, G Degols, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replicationJ P Leonetti, P Machy, G Degols, et al.
Nucleic Acids Research|June 28, 2000
A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type IIC Gongora, G Degols, L Espert, et al.
Nucleic Acids Research|November 25, 1989
Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNAG Degols, J P Leonetti, C Gagnor, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1992
[Control of gene expression by antisense nucleic acids]B Lebleu, J P Clarenc, G Degols, et al.
Antisense Research and Development|January 1, 1992
Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infectionG Degols, J P Leonetti, M Benkirane, et al.
Nucleic Acids Symposium Series|January 1, 1991
Nuclear location of synthetic oligonucleotides microinjected somatic cells: its implication in an antisense strategyN Mechti, J P Leonetti, J P Clarenc, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 1995
Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cellsB Bordier, M Perala-Heape, G Degols, et al.
Antiviral Research|July 1, 1993
Inhibition of HIV-1 replication in cultured cells with phosphorylated dideoxyuridine derivatives encapsulated in immunoliposomesO Zelphati, G Degols, H Loughrey, et al.
Journal of Medicinal Chemistry|January 22, 1993
Comparative evaluation of seven oligonucleotide analogues as potential antisense agentsF Morvan, H Porumb, G Degols, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Intracellular distribution of microinjected antisense oligonucleotidesJ P Leonetti, N Mechti, G Degols, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replicationJ P Leonetti, P Machy, G Degols, et al.
Nucleic Acids Research|June 28, 2000
A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type IIC Gongora, G Degols, L Espert, et al.
Nucleic Acids Research|November 25, 1989
Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNAG Degols, J P Leonetti, C Gagnor, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1992
[Control of gene expression by antisense nucleic acids]B Lebleu, J P Clarenc, G Degols, et al.
Antisense Research and Development|January 1, 1992
Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infectionG Degols, J P Leonetti, M Benkirane, et al.
Nucleic Acids Symposium Series|January 1, 1991
Nuclear location of synthetic oligonucleotides microinjected somatic cells: its implication in an antisense strategyN Mechti, J P Leonetti, J P Clarenc, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 1995
Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cellsB Bordier, M Perala-Heape, G Degols, et al.
Antiviral Research|July 1, 1993
Inhibition of HIV-1 replication in cultured cells with phosphorylated dideoxyuridine derivatives encapsulated in immunoliposomesO Zelphati, G Degols, H Loughrey, et al.
Journal of Medicinal Chemistry|January 22, 1993
Comparative evaluation of seven oligonucleotide analogues as potential antisense agentsF Morvan, H Porumb, G Degols, et al.
Pageof 2